{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "17045123", "DateCompleted": {"Year": "2007", "Month": "01", "Day": "04"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0188-4409", "JournalIssue": {"Volume": "37", "Issue": "8", "PubDate": {"Year": "2006", "Month": "Nov"}}, "Title": "Archives of medical research", "ISOAbbreviation": "Arch Med Res"}, "ArticleTitle": "Blood coagulation unaffected by ozonated autohemotherapy in patients on maintenance hemodialysis.", "Pagination": {"StartPage": "1034", "EndPage": "1037", "MedlinePgn": "1034-7"}, "Abstract": {"AbstractText": ["Ozonated autohemotherapy (O(3)-AHT) is a clinically useful therapeutic procedure in hemodialyzed patients with peripheral arterial occlusive disease (PAOD). The majority of patients on dialysis are in a hypercoagulable state. Thrombotic complications are the major cause of morbidity and mortality in hemodialyzed patients. Effects of O(3)-AHT on blood coagulation were evaluated in 11 hemodialyzed patients affected by PAOD.", "We performed an oxygen-controlled, crossover study in which nine sessions of autohemotherapy with oxygen administration (AHT) as a control were followed by nine sessions of O(3)-AHT. Blood coagulation was assessed by antithrombin III, activated partial thromboplastin time, prothrombin time, D-dimer and fibrinogen plasma concentrations.", "The extents of all the measured parameters after nine sessions of O(3)-AHT did not differ statistically from the values after nine sessions of AHT. Similarly, there were no differences in the measured variables after the first session of O(3)-AHT as compared to the values before therapy. We did not observe any thrombotic accidents during the study.", "O(3)-AHT with ozone concentration of 50 microg/mL and citrate as an anticoagulant does not influence blood coagualation parameters in hemodialyzed patients with PAOD."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland."}], "Identifier": [], "LastName": "Biedunkiewicz", "ForeName": "Bogdan", "Initials": "B"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lizakowski", "ForeName": "Slawomir", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Tylicki", "ForeName": "Leszek", "Initials": "L"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Skiboeska", "ForeName": "Anna", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Nieweglowski", "ForeName": "Tomas", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chamienia", "ForeName": "Andrzej", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Debska-Slizien", "ForeName": "Alicja", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Rutkowski", "ForeName": "Boleslaw", "Initials": "B"}], "PublicationTypeList": ["Clinical Trial", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Arch Med Res", "NlmUniqueID": "9312706", "ISSNLinking": "0188-4409"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["drug therapy", "therapy"], "DescriptorName": "Arterial Occlusive Diseases"}, {"QualifierName": ["drug effects"], "DescriptorName": "Blood Coagulation"}, {"QualifierName": [], "DescriptorName": "Blood Coagulation Tests"}, {"QualifierName": ["methods"], "DescriptorName": "Blood Transfusion, Autologous"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": ["drug therapy", "therapy"], "DescriptorName": "Peripheral Vascular Diseases"}, {"QualifierName": [], "DescriptorName": "Renal Dialysis"}, {"QualifierName": [], "DescriptorName": "Treatment Failure"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2006", "Month": "5", "Day": "11"}, {"Year": "2006", "Month": "6", "Day": "28"}, {"Year": "2006", "Month": "10", "Day": "19", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "1", "Day": "5", "Hour": "9", "Minute": "0"}, {"Year": "2006", "Month": "10", "Day": "19", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["17045123", "10.1016/j.arcmed.2006.06.006", "S0188-4409(06)00223-2"]}}], "PubmedBookArticle": []}